相关实验视频
Updated: Jun 25, 2026
06:09
Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
22.6K
单分子阵列测量LLRRK2激酶活性在血清中,将帕金森病的严重程度与外周炎症联系起来
Yuan Yuan1,2, Huizhong Li1,2, Kashyap Sreeram1,2
1Duke Center for Neurodegeneration and Neurotheraputics, Duke University, Durham, NC, USA.
Molecular neurodegeneration
|June 11, 2024
概括
一个新的生物标志物,化Rab10 (pT73-Rab10) 与总Rab10的血清比率,表明在异常性帕金森病 (iPD) 中LRRK2-相关的免疫激活. 升高的水平与iPD运动功能障碍相关,这表明LRRK2向治疗可能有好处.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 生物化学 生化学
背景情况:
- LRRK2激酶抑制剂正在针对异常性帕金森病 (iPD) 的临床试验中.
- LRRK2通过在内分泌体上酸化Rab10来影响免疫反应.
- 了解IPD中的Rab10酸化调节对于治疗开发至关重要.
研究的目的:
- 开发和验证一种高通量试验,用于测量细胞外化Rab10 (pT73-Rab10).
- 为了研究细胞外pT73-Rab10水平与异常性帕金森病 (iPD) 严重程度之间的关系.
- 确定影响细胞外pT73-Rab10水平的因素.
主要方法:
- 开发了一种单分子阵列试验,以量化血清中的细胞外pT73-Rab10.
- 将pT73-Rab10与转基因小鼠,大鼠和iPD患者与对照组的总Rab10比率进行了比较.
- 利用多变量和网络分析来确定pT73-Rab10/Rab10比率的预测变量.
主要成果:
- 在LRRK2/VPS35突变和SNCA表达中,血清pT73-Rab10水平升高,而在Lrrk2淘汰赛小鼠中则不存在.
- 骨髓移植研究表明循环免疫细胞是血清pT73-Rab10.10的主要来源.
- pT73-Rab10/Rab10比率随着炎症的增加而增加,随着LRRK2的抑制而减少,并且在较大的运动功能障碍的iPD患者中升高.
结论:
- 细胞外血清pT73-Rab10/Rab10比率是IPD中LRRK2-介导的先天性免疫激活的药理学生物标志物.
- 这种生物标志物与iPD疾病严重程度相关.
- 具有较高比例的iPD患者可能会从LRRK2向治疗中受益,以调节免疫反应.
更多相关视频
11:31Metabolic Labeling of Leucine Rich Repeat Kinases 1 and 2 with Radioactive Phosphate
Published on: September 18, 2013
10.0K
12:49Human Peripheral Blood Neutrophil Isolation for Interrogating the Parkinson's Associated LRRK2 Kinase Pathway by Assessing Rab10 Phosphorylation
Published on: March 21, 2020
7.5K
相关概念视频
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...